Medegen patent decision reversed


Medegen, a leading innovator in infusion therapy medical products, announced today that it has won an important legal victory in the United States Court of Appeals for the Federal Circuit in Washington, D.C. The appellate court’s decision reverses a judgment issued by a district court judge in the Central District of California of patent non-infringement entered in favor of ICU Medical Inc.

Medegen argued successfully that the decision below inappropriately narrowed the definition of key terms of one of its patents (U.S. Patent No. 5,730,418). This patent covers a number of Medegen’s novel inventions in needleless connectors, including the use of positive displacement technology.

Click here for the full story.

More IV news at IVTEAM


Comments are closed.